The effects by neuroleptics, antimycotics and antibiotics on disulfide reducing enzymes from the human pathogens Acanthamoeba polyphaga and Naegleria fowleri

Experimental Parasitology

Volumn 115, Issue 1, 2007, Pages 41-47

  Ondarza, Raúl N ^a,b,c   Iturbe, Angélica ^a   Hernández, Eva ^a  

^a INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Acanthamoeba polyphaga; Antibiotics; Antimycotics; Cysteine; Disulfide reducing enzymes; dithiothreitol; DTT; Glutathione; glutathione spermidine; Gspd; Human pathogens; mBBr; monobromobimane; N ethylmaleimide; Naegleria fowleri; NEM; Neuroleptics; oxidized trypanothione; PCA; perchloric acid; Potential drug targets; T(S)2; Trypanothione

Indexed keywords

AMPHOTERICIN B; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; CHLORPROMAZINE; CYSTINE REDUCTASE; DISULFIDE; DISULFIDE REDUCTASE; GLUTATHIONE REDUCTASE; KETOCONAZOLE; MEPACRINE; METRONIDAZOLE; MICONAZOLE; NEUROLEPTIC AGENT; OXIDOREDUCTASE; PENTAMIDINE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; RIFAMPICIN; TRIFLUOPERAZINE; TRYPANOTHIONE REDUCTASE; UNCLASSIFIED DRUG;

ACANTHAMOEBA; ACANTHAMOEBA POLYPHAGA; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; ENZYME INHIBITION; NAEGLERIA FOWLERI; NONHUMAN; PRIORITY JOURNAL; TROPHOZOITE;

ACANTHAMOEBA; ANIMALS; ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; ANTIPSYCHOTIC AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; GLUTATHIONE REDUCTASE; HUMANS; NADH, NADPH OXIDOREDUCTASES; NAEGLERIA FOWLERI;

ACANTHAMOEBA POLYPHAGA; NAEGLERIA FOWLERI;

EID: 33751175423     PISSN: 00144894     EISSN: 10902449     Source Type: Journal    
DOI: 10.1016/j.exppara.2006.05.006     Document Type: Article

References (20)

1. Argyrou A., and Blanchard J.S. Flavoprotein disulfide reductases: advances in chemistry and function. Progress in Nucleic Acid Research and Molecular Biology 78 (2004) 89-142
2. Chan C., Yin H., Garforth J., McKie J.H., Jaouhari R., Speers P., Douglas K.T., Rock P.J., Yardley V., Croft S.L., and Fairlamb A.H. Phenothiazine inhibitors of trypanothione reductase as potential antitrypanosomal and antileishmanial drugs. Journal of Medicinal Chemistry 41 (1998) 148-156
3. Fahey R.C., Newton G.L., Arrick B., Overdank-Bogart T., and Aley S.B. Entamoeba histolytica: a eukaryote without glutathione metabolism. Science 224 (1984) 70-72
4. Fairlamb A.H., Blackburn P., Ulrich P., Chait B.T., and Cerami A. Trypanothione: a novel bis (glutathionyl) spermidine cofactor for glutathione reductase in trypanosomatids. Science 227 (1985) 1485-1487
5. Ficker L., Seal D., Warhurst D., and Wright P. Acanthamoeba keratitis-resistance to medical therapy. Eye 4 Pt. 6 (1990) 835-838
6. Hargrave S.L., McCulley J.P., and Husseini Z. Results of a trial of combined propamidine isethionate and neomycin therapy for Acanthamoeba keratitis. Brolene Study Group. Ophthalmology 106 (1999) 952-957
7. Jacoby E.M., Schlichting I., Lantwin C.B., Kabsch W., and Krauth-Siegel R.L. Crystal structure of the Trypanosoma cruzi trypanothione reductase mepacrine complex. Proteins 24 1 (1996) 73-80
8. John D.T. Opportunistically pathogenic free-living amebae. In: Kreier J.P., and Baker J.R. (Eds). Parasitic Protozoa. second ed. vol. 3 (1993), Academic Press Inc., San Diego, California 143-246
9. Montrichard F., Le Guen F., Laval-Martin L.D., and Davioud-Charvet E. Evidence for the co-existence of glutathione reductase and trypanothione reductase in the nontrypanosomatid Euglenozoa: Euglena gracilis Z. FEBS Letters 442 (1999) 29-33
10. Ondarza R.N., Iturbe A., Hernandez E., Tamayo E.M., and Hurtado G. In vivo inhibition of reduced thiol compounds from Entamoeba histolytica HK9 by phenothiazines and related tricyclic drugs. Archives of Medical Research 31 Suppl. 4 (2000) S12-S16
11. Ondarza R.N., Hernandez E., Iturbe A., and Hurtado G. Inhibitory and lytic effects of phenothiazine derivatives and related tricyclic neuroleptic compounds, on Entamoeba histolytica HK9 and HM1 trophozoites. Biotechnology and Applied Biochemistry 32 Pt. 1 (2000) 61-67
12. Ondarza R.N., Iturbe A., Hernández E., and Hurtado G. Thiol compounds from a free-living opportunistic amoeba, Acanthamoeba polyphaga. Biotechnology and Applied Biochemistry 36 (2002) 195-204
13. Ondarza R.N., Iturbe A., Hernández E., and Hurtado G. Low-molecular-mass thiol compounds from a free-living highly pathogenic amoeba, Naegleria fowleri. Biotechnology and Applied Biochemistry 37 (2003) 195-204
14. Ondarza R.N., Hurtado G., Iturbe A., Hernández E., Tamayo E., and Woolery M. Identification of trypanothione from the human pathogen Entamoeba histolytica by mass spectrometry and chemical analysis. Biotechnology and Applied Biochemistry 42 (2005) 175-181
15. Ondarza, R.N., Iturbe, A., Hernández, E., 2006a. Antiproliferative Effects In vitro by Neuroleptics, Antimycotics and Antibiotics, on the Human Pathogens Acanthamoeba polyphaga and Naegleria fowleri. Archives of Medical Research (in press).
16. Ondarza, R.N., Hurtado,G., Tamayo, E.,Iturbe, A., Hernandez, E., 2006b. Naegleria fowleri: A free-living highly pathogenic amoeba contains trypanothione/trypanothione reductase and glutathione/glutathione reductase systems. Experimental Parasitology (in press).
17. Rivera F., Roy-Ocotla G., Rosas I., Rami{dotless}́rez E., Bonilla P., and Lares F. Amoebae isolated from the atmosphere of Mexico City and environs. Environmental Research 42 1 (1987) 149-154
18. Saravanamuthu A., Vickers T.J., Bond C.S., Peterson M.R., Hunter W.N., and Fairlamb A.H. Two interacting binding sites for quinacrine derivatives in the active site of trypanothione reductase: a template for drug design. Journal of Biological Chemistry 279 28 (2004) 29493-29500
19. Shames S.L., Fairlamb A.H., Cerami A., and Walsh C.T. Purification and characterization of trypanothione reductase from Crithidia fasciculata, a newly discovered member of the family of disulfide-containing flavoprotein reductases. Biochemistry 25 (1986) 3519-3526
20. Tamayo E.M., Iturbe A., Hernández E., Hurtado G., Gutiérrez - X.M.L., Rosales J.L., Woolery M., and Ondarza R.N. Trypanothione reductase from the human parasite Entamoeba histolytica: a new drug target. Biotechnology and Applied Biochemistry 41 (2005) 105-115